Judith Giri

Judith Giri

Auto-generated profile, based on publicly available information

Judith Giri

Colorado School of Public Health

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
JGJudith Giri
Judith Giri
LPLaura Pezzi
Laura Pezzi
RCRodrigo Cachay
Rodrigo Cachay
RRRosa Margarita Gèlvez Ramirez
Rosa Margarita Gèlvez Ramirez
ATAdriana Tami
Adriana Tami
MCMay Chu
May Chu
We present a framework for a federated, virtual biorepository system (VBS) with locally collected and managed specimens, as a ‘global public good’ model based on principles of equitable access and benefit sharing. The VBS is intended to facilitate timely access to biological specimens and associated data for outbreak-prone infectious diseases to accelerate the development and evaluation of diagnostics, assess vaccine efficacy, and to support surveillance and research needs. The VBS is aimed to be aligned with the WHO BioHub and other specimen sharing efforts as a force multiplier to meet the needs of strengthening global tools for countering epidemics. The purpose of our initial research is to lay the basis of the collaboration, management and principles of equitable sharing focused on low- and middle-income country partners. Here we report on surveys and interviews undertaken with biorepository-interested parties to better understand needs and barriers for specimen access and share examples from the ZIKAlliance partnership on the governance and operations of locally organized biorepositories.

22 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
APAmy Price
Amy Price
LALayla Abdulbaki
Layla Abdulbaki
JPJulia Poje
Julia Poje
JGJudith Giri
Judith Giri
GWGeoffrey Winstanley
Geoffrey Winstanley
MCMay Chu
May Chu
Background: The re-emergence of Zika virus, the novel coronavirus, and new influenza strains highlighted the urgent need for an organized forum to access specimens for advancing research, diagnostics and vaccine development. A Virtual Biorepository System (VBS) was proposed to connect communities and samples, addressing specimen-sharing challenges while promoting inclusion and equity. Aim and Objectives: To enable equitable contribution, sharing, and access to specimens while addressing the complexities involved. The objective is to build stakeholder consensus on prioritized actions, tools, and responsibilities to establish a functional and practical VBS. Methods: A Delphi process was conducted online to gather stakeholder input and develop a prioritized action plan for the VBS. Respondents were recruited using snowball sampling, and questions were informed by participatory workshops, feedback, outreach efforts, and discussions to identify gaps and best practices. The Delphi process consisted of two rounds: an initial ranking informed by stakeholder inputs and a second round of refining priorities based on panel feedback. Consensus threshold was defined as ≥70% of responses rating an item ≥4 and excluded if an item had ≤15% response or was rated < 2 on a 1–5 Likert scale. Advisory board discussions supplemented the virtual process to capture nuances, while qualitative data were analyzed using participatory action research methods. Findings: The Delphi process identified critical gaps and priorities in biorepository systems. Consensus was reached for 22 out of 30 items. Items 20 of 26 in Round-1, with 2 of 4 additional items in Round-2 where consensus was reached on 2 items addressing benefit-sharing challenges (73%) and prioritizing whole blood, plasma, and serum samples (95%). Respondents overwhelmingly supported a hybrid VBS model combining federated and centralized systems (83%) cost recovery for services (100%) Some respondents suggested an equitable fee structure using a sliding scale to subsidize capacity building in low-and middle-income countries (95%). Conclusions: Respondents strongly supported a VBS to enable equitable access to specimens, services, and benefits. They emphasized the need for clarity on benefit-sharing, regulatory, and ethical frameworks to ensure effective implementation and global inclusivity. A fair and equivalent system to enhance participation and operational continuity is being discussed.

12 November 2026 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
APAmy Price
Amy Price
LALayla Abdulbaki
Layla Abdulbaki
JPJulia Poje
Julia Poje
JGJudith Giri
Judith Giri
ZSZoe Steinberg
Zoe Steinberg
MCMay Chu
May Chu
Background: The reemergence of the Zika virus, the novel coronavirus, and new influenza strains highlighted the urgent need for an organized forum to access specimens to advance research, diagnostics, and vaccine development. During the COVID-19 pandemic, gaps in supply chains, communication, and standards between local (federated) and centralized systems cost time and lives. The FAIR-VBS (Federated, Accessible, Inclusive, and Responsive Virtual Biorepository) was proposed to connect communities with samples, address specimen-sharing challenges, and promote inclusion and equity. Objective: This study aims to enable equitable contribution, sharing, and access to specimens while addressing the complexities involved. The objective is to build stakeholder consensus on prioritized actions, tools, and responsibilities to establish a functional and practical FAIR-VBS. Methods: A Delphi process was conducted online to gather stakeholder input and develop a prioritized action plan for the FAIR-VBS. Respondents were recruited using snowball sampling, and questions were informed by participatory workshops, feedback, outreach efforts, and discussions to identify gaps and best practices. The Delphi process consisted of 2 rounds: an initial ranking informed by stakeholder input and a second round to refine priorities based on the panel feedback. Items were evaluated using a standardized 5-point Likert scale and retained if prioritized by at least 70% of respondents rating an item 4 or higher and no more than 15% rating an item below 2, with descriptive statistics applied. Advisory board discussions supplemented the virtual process to capture nuances, while qualitative data were analyzed using participatory action research methods. Results: The Delphi process evaluated 34 cumulative items across 2 rounds to identify critical gaps and priorities in biorepository systems. In the first round, 22 out of 30 initial items successfully reached consensus. Panelists organically proposed 4 additional items during the first round; upon evaluation in the second round, 2 of these newly proposed items reached consensus, addressing benefit-sharing challenges (11/15, 73%) and the prioritization of whole blood, plasma, and serum samples (40/42, 95%). Culturally, peripheral blood mononuclear cells were supported as a secondary priority (13/18, 72%). In total, 24 items achieved consensus across both rounds, while 10 items overall did not. Respondents overwhelmingly supported the hybrid FAIR-VBS, which combines federated and centralized systems, offering local convenience with virtual oversight (34/41, 83%). Cost recovery for services was supported by all respondents (43/43, 100%), with a preference for a sliding fee scale to subsidize capacity building in low- and middle-income countries (40/42, 95%). Conclusions: Respondents strongly supported the FAIR-VBS to enable equitable access to specimens, services, and benefits. They emphasized the need for clarity on benefit-sharing, regulatory, and ethical frameworks to ensure effective implementation and global inclusivity. A fair and equivalent system to enhance participation and operational continuity is being discussed.

18 January 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JGJudith Giri
Judith Giri
LPLaura Pezzi
Laura Pezzi
RFRodrigo Antonio Figueroa
Rodrigo Antonio Figueroa
RRRosa Margarita Gelvez Ramirez
Rosa Margarita Gelvez Ramirez
ATAdirana Tami
Adirana Tami
MCMay Chu
May Chu
We present a framework for a federated, virtual biorepository system (VBS) with locally collected and maintained specimens, based on a ‘global goods’ model and principles of equitable access and benefit sharing. The VBS is intended to facilitate timely access to biological specimens and associated data for outbreak-prone infectious diseases to accelerate the development and evaluation of diagnostics, assess vaccine efficacy, and to support surveillance and research needs. The VBS is aimed to be aligned with the WHO BioHub and other specimen sharing efforts as a force multiplier to meet the needs of strengthening global tools for countering epidemics. The purpose of our research is to lay the basis of the collaboration, management and principles of equitable sharing focused on low- and middle-income country partners. Here we report on surveys and interviews undertaken with biorepository-interested parties to better understand needs and barriers for specimen access and share examples from the ZIKAlliance partnership on the governance and operations of locally organized biorepositories.